                         SEQUENCE LISTING

<110>  Yissum Research Development Company of The Hebrew 
       University of Jerusalem Ltd.
 
<120>  PEPTIDES FOR THE TREATMENT OF CANCER

<130>  YISSUM/158 PCT

<150>  US 62/846,757
<151>  2019-05-13

<160>  5     

<170>  PatentIn version 3.5

<210>  1
<211>  33
<212>  PRT
<213>  Homo sapiens

<400>  1

Ser Ala Arg Leu Asn Ser Gln Arg Leu Val Phe Asn Arg Pro Phe Leu 
1               5                   10                  15      


Met Phe Ile Val Asp Asn Asn Ile Leu Phe Leu Gly Lys Val Asn Arg 
            20                  25                  30          


Pro 
    


<210>  2
<211>  406
<212>  PRT
<213>  Homo sapiens

<400>  2

Met Gln Leu Phe Leu Leu Leu Cys Leu Val Leu Leu Ser Pro Gln Gly 
1               5                   10                  15      


Ala Ser Leu His Arg His His Pro Arg Glu Met Lys Lys Arg Val Glu 
            20                  25                  30          


Asp Leu His Val Gly Ala Thr Val Ala Pro Ser Ser Arg Arg Asp Phe 
        35                  40                  45              


Thr Phe Asp Leu Tyr Arg Ala Leu Ala Ser Ala Ala Pro Ser Gln Ser 
    50                  55                  60                  


Ile Phe Phe Ser Pro Val Ser Ile Ser Met Ser Leu Ala Met Leu Ser 
65                  70                  75                  80  


Leu Gly Ala Gly Ser Ser Thr Lys Met Gln Ile Leu Glu Gly Leu Gly 
                85                  90                  95      


Leu Asn Leu Gln Lys Ser Ser Glu Lys Glu Leu His Arg Gly Phe Gln 
            100                 105                 110         


Gln Leu Leu Gln Glu Leu Asn Gln Pro Arg Asp Gly Phe Gln Leu Ser 
        115                 120                 125             


Leu Gly Asn Ala Leu Phe Thr Asp Leu Val Val Asp Leu Gln Asp Thr 
    130                 135                 140                 


Phe Val Ser Ala Met Lys Thr Leu Tyr Leu Ala Asp Thr Phe Pro Thr 
145                 150                 155                 160 


Asn Phe Arg Asp Ser Ala Gly Ala Met Lys Gln Ile Asn Asp Tyr Val 
                165                 170                 175     


Ala Lys Gln Thr Lys Gly Lys Ile Val Asp Leu Leu Lys Asn Leu Asp 
            180                 185                 190         


Ser Asn Ala Val Val Ile Met Val Asn Tyr Ile Phe Phe Lys Ala Lys 
        195                 200                 205             


Trp Glu Thr Ser Phe Asn His Lys Gly Thr Gln Glu Gln Asp Phe Tyr 
    210                 215                 220                 


Val Thr Ser Glu Thr Val Val Arg Val Pro Met Met Ser Arg Glu Asp 
225                 230                 235                 240 


Gln Tyr His Tyr Leu Leu Asp Arg Asn Leu Ser Cys Arg Val Val Gly 
                245                 250                 255     


Val Pro Tyr Gln Gly Asn Ala Thr Ala Leu Phe Ile Leu Pro Ser Glu 
            260                 265                 270         


Gly Lys Met Gln Gln Val Glu Asn Gly Leu Ser Glu Lys Thr Leu Arg 
        275                 280                 285             


Lys Trp Leu Lys Met Phe Lys Lys Arg Gln Leu Glu Leu Tyr Leu Pro 
    290                 295                 300                 


Lys Phe Ser Ile Glu Gly Ser Tyr Gln Leu Glu Lys Val Leu Pro Ser 
305                 310                 315                 320 


Leu Gly Ile Ser Asn Val Phe Thr Ser His Ala Asp Leu Ser Gly Ile 
                325                 330                 335     


Ser Asn His Ser Asn Ile Gln Val Ser Glu Met Val His Lys Ala Val 
            340                 345                 350         


Val Glu Val Asp Glu Ser Gly Thr Arg Ala Ala Ala Ala Thr Gly Thr 
        355                 360                 365             


Ile Phe Thr Phe Arg Ser Ala Arg Leu Asn Ser Gln Arg Leu Val Phe 
    370                 375                 380                 


Asn Arg Pro Phe Leu Met Phe Ile Val Asp Asn Asn Ile Leu Phe Leu 
385                 390                 395                 400 


Gly Lys Val Asn Arg Pro 
                405     


<210>  3
<211>  387
<212>  PRT
<213>  Homo sapiens

<400>  3

His Arg His His Pro Arg Glu Met Lys Lys Arg Val Glu Asp Leu His 
1               5                   10                  15      


Val Gly Ala Thr Val Ala Pro Ser Ser Arg Arg Asp Phe Thr Phe Asp 
            20                  25                  30          


Leu Tyr Arg Ala Leu Ala Ser Ala Ala Pro Ser Gln Ser Ile Phe Phe 
        35                  40                  45              


Ser Pro Val Ser Ile Ser Met Ser Leu Ala Met Leu Ser Leu Gly Ala 
    50                  55                  60                  


Gly Ser Ser Thr Lys Met Gln Ile Leu Glu Gly Leu Gly Leu Asn Leu 
65                  70                  75                  80  


Gln Lys Ser Ser Glu Lys Glu Leu His Arg Gly Phe Gln Gln Leu Leu 
                85                  90                  95      


Gln Glu Leu Asn Gln Pro Arg Asp Gly Phe Gln Leu Ser Leu Gly Asn 
            100                 105                 110         


Ala Leu Phe Thr Asp Leu Val Val Asp Leu Gln Asp Thr Phe Val Ser 
        115                 120                 125             


Ala Met Lys Thr Leu Tyr Leu Ala Asp Thr Phe Pro Thr Asn Phe Arg 
    130                 135                 140                 


Asp Ser Ala Gly Ala Met Lys Gln Ile Asn Asp Tyr Val Ala Lys Gln 
145                 150                 155                 160 


Thr Lys Gly Lys Ile Val Asp Leu Leu Lys Asn Leu Asp Ser Asn Ala 
                165                 170                 175     


Val Val Ile Met Val Asn Tyr Ile Phe Phe Lys Ala Lys Trp Glu Thr 
            180                 185                 190         


Ser Phe Asn His Lys Gly Thr Gln Glu Gln Asp Phe Tyr Val Thr Ser 
        195                 200                 205             


Glu Thr Val Val Arg Val Pro Met Met Ser Arg Glu Asp Gln Tyr His 
    210                 215                 220                 


Tyr Leu Leu Asp Arg Asn Leu Ser Cys Arg Val Val Gly Val Pro Tyr 
225                 230                 235                 240 


Gln Gly Asn Ala Thr Ala Leu Phe Ile Leu Pro Ser Glu Gly Lys Met 
                245                 250                 255     


Gln Gln Val Glu Asn Gly Leu Ser Glu Lys Thr Leu Arg Lys Trp Leu 
            260                 265                 270         


Lys Met Phe Lys Lys Arg Gln Leu Glu Leu Tyr Leu Pro Lys Phe Ser 
        275                 280                 285             


Ile Glu Gly Ser Tyr Gln Leu Glu Lys Val Leu Pro Ser Leu Gly Ile 
    290                 295                 300                 


Ser Asn Val Phe Thr Ser His Ala Asp Leu Ser Gly Ile Ser Asn His 
305                 310                 315                 320 


Ser Asn Ile Gln Val Ser Glu Met Val His Lys Ala Val Val Glu Val 
                325                 330                 335     


Asp Glu Ser Gly Thr Arg Ala Ala Ala Ala Thr Gly Thr Ile Phe Thr 
            340                 345                 350         


Phe Arg Ser Ala Arg Leu Asn Ser Gln Arg Leu Val Phe Asn Arg Pro 
        355                 360                 365             


Phe Leu Met Phe Ile Val Asp Asn Asn Ile Leu Phe Leu Gly Lys Val 
    370                 375                 380                 


Asn Arg Pro 
385         


<210>  4
<211>  33
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide


<220>
<221>  MISC_FEATURE
<222>  (17)..(17)
<223>  Methionine-sulfoxide

<400>  4

Ser Ala Arg Leu Asn Ser Gln Arg Leu Val Phe Asn Arg Pro Phe Leu 
1               5                   10                  15      


Met Phe Ile Val Asp Asn Asn Ile Leu Phe Leu Gly Lys Val Asn Arg 
            20                  25                  30          


Pro 
    


<210>  5
<211>  33
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  N-terminal Biotin-Ahx

<400>  5

Ser Ala Arg Leu Asn Ser Gln Arg Leu Val Phe Asn Arg Pro Phe Leu 
1               5                   10                  15      


Met Phe Ile Val Asp Asn Asn Ile Leu Phe Leu Gly Lys Val Asn Arg 
            20                  25                  30          


Pro 
    


